Petros D. Petridis

Petros D. Petridis

Auto-generated profile, based on publicly available information

Petros D. Petridis

Department of Psychiatry, Grossman School of Medicine, New York University, New York, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
THTodd C. Hollon
Todd C. Hollon
BPBalaji Pandian
Balaji Pandian
AAArjun R. Adapa
Arjun R. Adapa
EUEsteban Urias
Esteban Urias
ASAkshay V. Save
Akshay V. Save
DODaniel A. Orringer
Daniel A. Orringer

14 May 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DPDarja Marolt Presen
Darja Marolt Presen
ICIván Marcos Campos
Iván Marcos Campos
SBSarindr Bhumiratana
Sarindr Bhumiratana
AKAna Koren
Ana Koren
PPPetros Petridis
Petros Petridis
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
In extensive bone defects, tissue damage and hypoxia lead to cell death, resulting in slow and incomplete healing. Human embryonic stem cells (hESC) can give rise to all specialized lineages found in healthy bone and are therefore uniquely suited to aid regeneration of damaged bone. We show that the cultivation of hESC-derived mesenchymal progenitors on 3D osteoconductive scaffolds in bioreactors with medium perfusion leads to the formation of large and compact bone constructs. Notably, the implantation of engineered bone in immunodeficient mice for 8 wk resulted in the maintenance and maturation of bone matrix, without the formation of teratomas that is consistently observed when undifferentiated hESCs are implanted, alone or in bone scaffolds. Our study provides a proof of principle that tissue-engineering protocols can be successfully applied to hESC progenitors to grow bone grafts for use in basic and translational studies.

1 November 2012 in Biomaterials
Verified
Journal Article
Closed access
IMIvan Marcos-Campos
Ivan Marcos-Campos
DPDarja Marolt Presen
Darja Marolt Presen
PPPetros Petridis
Petros Petridis
SBSarindr Bhumiratana
Sarindr Bhumiratana
DSDaniel Frederick Schmidt
Daniel Frederick Schmidt
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic

7 April 2017 in Global Spine Journal
Verified
Journal Article
Open access
CSComron Saifi
Comron Saifi
JLJoseph L. Laratta
Joseph L. Laratta
PPPetros Petridis
Petros Petridis
JSJamal N. Shillingford
Jamal N. Shillingford
RLRonald A. Lehman
Ronald A. Lehman
LLLawrence G. Lenke
Lawrence G. Lenke
Study Design: Broad narrative review. Objective: To review the evolution, operative technique, outcomes, and complications associated with posterior vertebral column resection. Methods: A literature review of posterior vertebral column resection was performed. The authors’ surgical technique is outlined in detail. The authors’ experience and the literature regarding vertebral column resection are discussed at length. Results: Treatment of severe, rigid coronal and/or sagittal malalignment with posterior vertebral column resection results in approximately 50–70% correction depending on the type of deformity. Surgical site infection rates range from 2.9% to 9.7%. Transient and permanent neurologic injury rates range from 0% to 13.8% and 0% to 6.3%, respectively. Although there are significant variations in EBL throughout the literature, it can be minimized by utilizing tranexamic acid intraoperatively. Conclusion: The ability to correct a rigid deformity in the spine relies on osteotomies. Each osteotomy is associated with a particular magnitude of correction at a single level. Posterior vertebral column resection is the most powerful posterior osteotomy method providing a successful correction of fixed complex deformities. Despite meticulous surgical technique and precision, this robust osteotomy technique can be associated with significant morbidity even in the most experienced hands.

16 September 2015 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
EMEric C. Makhni
Eric C. Makhni
APAjay S. Padaki
Ajay S. Padaki
PPPetros D. Petridis
Petros D. Petridis
MSMichael E. Steinhaus
Michael E. Steinhaus
CAChristopher S. Ahmad
Christopher S. Ahmad
BBBernard R. Bach
Bernard R. Bach
ACL (anterior cruciate ligament) reconstruction is one of the most commonly performed and studied procedures in modern sports medicine. A multitude of objective and subjective patient outcome measures exists; however, nonstandardized reporting patterns of these metrics may create challenges in objectively analyzing pooled results from different studies. The goal of this study was to document the variability in outcome reporting patterns in high-impact orthopaedic studies of ACL reconstruction. All clinical studies pertaining to ACL reconstruction in four high-impact-factor orthopaedic journals over a five-year period were reviewed. Biomechanical, basic science, and imaging studies were excluded, as were studies with fewer than fifty patients, yielding 119 studies for review. Incorporation of various objective and subjective outcomes was noted for each study. Substantial variability in reporting of both objective and subjective measures was noted in the study cohort. Although a majority of studies reported instrumented laxity findings, there was substantial variability in the type and method of laxity reporting. Most other objective outcomes, including range of motion, strength, and complications, were reported in <50% of all studies. Return to pre-injury level of activity was infrequently reported (24% of studies), as were patient satisfaction and pain assessment following surgery (8% and 13%, respectively). Of the patient-reported outcomes, the International Knee Documentation Committee (IKDC), Lysholm, and Tegner scores were most often reported (71%, 63%, and 42%, respectively). Substantial variability in outcome reporting patterns exists among high-impact studies of ACL reconstruction. Such variability may create challenges in interpreting results and pooling them across different studies.

1 December 2017 in Journal of Neurosurgery
Verified
Journal Article
Closed access
Randy D'AmicoRandy D'Amico
Randy D'Amico
MBMatei A. Banu
Matei A. Banu
PPPetros Petridis
Petros Petridis
ABAlexandra S. Bercow
Alexandra S. Bercow
HMHani Malone
Hani Malone
MSMichael B. Sisti
Michael B. Sisti
OBJECTIVE: Advanced microsurgical techniques contribute to reduced morbidity and improved surgical management of meningiomas arising within the cerebellopontine angle (CPA). However, the goal of surgery has evolved to preserve the quality of the patient's life, even if it means leaving residual tumor. Concurrently, Gamma Knife radiosurgery (GKRS) has become an acceptable and effective treatment modality for newly diagnosed, recurrent, or progressive meningiomas of the CPA. The authors review their institutional experience with CPA meningiomas treated with GKRS, surgery, or a combination of surgery and GKRS. They specifically focus on rates of facial nerve preservation and characterize specific anatomical features of tumor location with respect to the internal auditory canal (IAC).METHODS: Medical records of 76 patients with radiographic evidence or a postoperative diagnosis of CPA meningioma, treated by a single surgeon between 1992 and 2016, were retrospectively reviewed. Patients with CPA meningiomas smaller than 2.5 cm in greatest dimension were treated with GKRS, while patients with tumors 2.5 cm or larger underwent facial nerve–sparing microsurgical resection where appropriate. Various patient, clinical, and tumor data were gathered. Anatomical features of the tumor origin as seen on preoperative imaging confirmed by intraoperative investigation were evaluated for prognostic significance. Facial nerve preservation rates were evaluated.RESULTS: According to our treatment paradigm, 51 (67.1%) patients underwent microsurgical resection and 25 (32.9%) patients underwent GKRS. Gross-total resection (GTR) was achieved in 34 (66.7%) patients, and subtotal resection (STR) in 17 (33.3%) patients. Tumors recurred in 12 (23.5%) patients initially treated surgically, requiring additional surgery and/or GKRS. Facial nerve function was unchanged or improved in 68 (89.5%) patients. Worsening facial nerve function occurred in 8 (10.5%) patients, all of whom had undergone microsurgical resection. Upfront treatment with GKRS for CPA meningiomas smaller than 2.5 cm was associated with preservation of facial nerve function in all patients over a median follow-up of 46 months, regardless of IAC invasion and tumor origin. Anatomical origin was associated with extent of resection but did not correlate with postoperative facial nerve function. Tumor size, extent of resection, and the presence of an arachnoid plane separating the tumor and the contents of the IAC were associated with postoperative facial nerve outcomes.CONCLUSIONS: CPA meningiomas remain challenging lesions to treat, given their proximity to critical neurovascular structures. GKRS is a safe and effective option for managing CPA meningiomas smaller than 2.5 cm without associated mass effect or acute neurological symptoms. Maximal safe resection with preservation of neurological function can be performed for tumors 2.5 cm or larger without significant risk of facial nerve dysfunction, and, when combined with GKRS for recurrence and/or progression, provides excellent disease control. Anatomical features of the tumor origin offer critical insights for optimizing facial nerve preservation in this cohort.